drugset / Trial / NCT01639768

SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding

NCT01639768 ↗

Phase 2 Completed 270 enrolled HAL Allergy
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to determine the optimal effective dose of SUBLIVAC FIX Birch based on reduction of upper airways reactivity after 5 months of treatment with different dosages of SUBLIVAC FIX Birch compared to placebo. Furthermore, safety and tolerability will be assessed by the number of related Adverse Events of different dosages of SUBLIVAC FIX Birch compared to placebo.

Timeline

Start
2012-07
Primary completion
2013-03
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator SUBLIVAC FIX Birch Unknown 3333 unknown Other
Comparator SUBLIVAC FIX Birch Unknown 10000 unknown Other
Comparator SUBLIVAC FIX Birch Unknown 20000 unknown Other
Comparator SUBLIVAC FIX Birch Unknown 40000 unknown Other

Indications